component-social-facebook_share_api-v2-01
      34
      Thursday
      56 / 34
      Friday
      55 / 29
      Saturday
      44 / 22

      Your Health 5-13-13 New COPD treatment

      {} {} The U.S. Food and Drug Administration has approved a new drug to treat a lung disease that is the third leading cause of death among Americans.{}{}{}{}{}{} The agency gave the green light for the drug, Breo Ellipta to treat chronic obstructive pulmonary disease, also known as COPD.{}{}{} It's approved to for use among patients with COPD, including chronic bronchitis and/or emphysema.{}{}{}{}{}{} The FDA says the drug works by decreasing airflow in the lungs and helping muscles around the airways of the lungs stay relaxed in order to increase airflow.{}{}{}{} Serious side effects associated with the drug include increased risks of pneumonia and bone fractures. {}{}{}{} The most common side effects include inflammation of the nasal passage, upper respiratory tract infection, and headache.

      FOLLOW US ON TWITTER